Lengana

Lengana (Artemisia afra) contains sesquiterpenes (artemin, artesin, maritimin), flavonoids, acetophenones, and phenolic compounds that collectively exert antioxidant, anti-inflammatory, antimalarial, and bronchodilatory effects through radical scavenging and erythrocytic stage inhibition of Plasmodium species. In preclinical studies, its leaf DCM extract achieved 94.28% inhibition of malaria parasitemia at 200 mg/kg body weight in animal models, and a hydro-ethanol extract demonstrated an IC50 of 0.46 μg/mL against the erythrocytic stage in vitro.

Origin & History

Artemisia afra, commonly called African wormwood or lengana, is indigenous to sub-Saharan Africa, growing widely across Zimbabwe, South Africa, Ethiopia, and extending into parts of East and Central Africa. It thrives in grasslands, rocky hillsides, forest margins, and disturbed soils at altitudes ranging from 1,000 to 3,000 meters, preferring well-drained, moderately fertile soils with adequate sunlight. The plant has been cultivated in homestead gardens throughout southern Africa for centuries due to its medicinal prominence, and it grows as a perennial aromatic shrub with finely divided silver-grey leaves that release a distinctive camphor-like scent when crushed.

Historical & Cultural Context

Artemisia afra holds one of the most prominent positions in sub-Saharan African traditional medicine, with documented use spanning centuries across Zimbabwe, South Africa, Lesotho, Swaziland, and East African nations, where it is regarded as a near-universal remedy by traditional healers (sangomas and inyangas). In Zimbabwe, where it is known as lengana, the plant is central to management of respiratory ailments including coughs, colds, and asthma, as well as malaria, fever, intestinal worms, and pain — a breadth of application reflecting deep cultural confidence in its efficacy. Preparations traditionally include steam inhalation over boiling leaf decoctions, oral infusions, and topical poultices applied to wounds or arthritic joints, with preparation methods transmitted through oral tradition and community healers. The plant is referenced across ethnobotanical surveys as one of the most frequently cited medicinal plants in southern Africa, with the Sotho name 'lengana' and Zulu equivalent 'umhlonyane' both widely recognized, underscoring its cross-cultural significance in the region.

Health Benefits

- **Antimalarial Activity**: Leaf extracts demonstrate potent in vitro inhibition of Plasmodium erythrocytic stages (IC50 0.46 μg/mL), with sesquiterpene lactones and guaianolide compounds (1α,4α-dihydroxybishopsolicepolide) implicated as key active constituents against the parasite.
- **Antioxidant Protection**: Flavonoids, phenolic acids, and tannins contribute to strong DPPH radical scavenging and hydrogen peroxide inhibition, with total phenol and flavonoid content correlating positively with antioxidant potency across Artemisia species.
- **Respiratory Support and Bronchodilation**: Traditional use for coughs, colds, bronchitis, and asthma is supported by experimental evidence of bronchodilatory activity, likely mediated by monoterpenes and sesquiterpenes in the volatile essential oil fraction relaxing bronchial smooth muscle.
- **Anti-inflammatory Effects**: Monoterpenes, sesquiterpenes, and polyphenols in A. afra modulate inflammatory pathways, reducing pro-inflammatory mediator activity in experimental models and rationalizing its traditional application for fever and pain management.
- **Antimicrobial and Antifungal Activity**: Phenolic compounds, acetophenones (2,4-dihydroxy-6-methoxyacetophenone, p-hydroxyacetophenone), and essential oil constituents exhibit broad-spectrum antimicrobial and antifungal effects against multiple pathogenic organisms in vitro.
- **Immunomodulation**: Polyphenols and terpenoids in the leaf extract demonstrate immunomodulating properties in experimental systems, potentially enhancing host defense responses relevant to infections managed in traditional Zimbabwean medicine.
- **Gastrointestinal and Fever Management**: Traditionally used across Zimbabwe and southern Africa for digestive complaints and fever reduction, with bitter sesquiterpene lactones and aromatic compounds supporting digestive enzyme activity and antipyretic mechanisms.

How It Works

The sesquiterpene lactones and guaianolide compound 1α,4α-dihydroxybishopsolicepolide in A. afra are thought to interfere with Plasmodium falciparum erythrocytic stage replication, possibly through alkylation of heme molecules or inhibition of parasite-specific enzymes analogous to mechanisms described for artemisinin in related Artemisia species. Flavonoids and phenolic acids (including gallic and tannic acid analogs) donate hydrogen atoms to neutralize reactive oxygen species via DPPH radical scavenging and hydrogen peroxide decomposition, reducing oxidative stress in affected tissues. Monoterpenes and sesquiterpenes in the essential oil fraction are proposed to modulate inflammatory signaling by inhibiting pro-inflammatory enzymes such as cyclooxygenase and lipoxygenase, while also exerting direct bronchospasmolytic effects on airway smooth muscle through calcium channel modulation. Acetophenones, particularly 2,4-dihydroxy-6-methoxyacetophenone, contribute antimicrobial activity by disrupting microbial cell membrane integrity, and the combined polyphenol load supports immunomodulation through modulation of cytokine release, though specific receptor-level pathways in A. afra remain incompletely characterized in published literature.

Scientific Research

The evidence base for Artemisia afra is exclusively preclinical, comprising in vitro and animal model studies with no published human clinical trials reporting sample sizes or effect sizes as of current available data. In vitro studies have quantified antimalarial activity of leaf hydro-ethanol extracts at IC50 0.46 μg/mL against the erythrocytic stage of Plasmodium, and in vivo murine models demonstrated 94.28% parasitemia inhibition at a dose of 200 mg/kg body weight using a DCM leaf extract. Experimental models have confirmed antimicrobial, antifungal, anti-inflammatory, antioxidant, and bronchodilatory activities, providing pharmacological plausibility for traditional applications, but the absence of standardized phytochemical concentrations, pharmacokinetic data, and human trials substantially limits translation of these findings to clinical recommendations. The research quality is further constrained by lack of dose-response standardization, variability in plant material sourcing, and no published randomized controlled trials, placing the overall evidence squarely at a preclinical-only level.

Clinical Summary

No human clinical trials for Artemisia afra have been identified in the published literature, meaning all efficacy data originate from in vitro cell-based assays and in vivo animal experiments. The most robustly quantified outcome is antimalarial activity: a DCM leaf extract produced 94.28% inhibition of Plasmodium parasitemia at 200 mg/kg in an animal model, and a hydro-ethanol extract achieved IC50 0.46 μg/mL in erythrocytic stage inhibition assays. Anti-inflammatory, antioxidant, antimicrobial, and bronchodilator effects have been demonstrated experimentally but without human efficacy or safety endpoints, effect sizes in human populations, or confidence intervals. Confidence in clinical benefit for human populations remains low pending controlled human studies, and current use is supported primarily by traditional evidence and biological plausibility rather than clinical proof.

Nutritional Profile

Artemisia afra leaves contain a complex array of phytochemicals rather than notable macronutrient or micronutrient content. Carbohydrate-associated compounds identified include the sugars arabinose, fucose, galactose, glucose, and mannose, alongside uronic acids (galacturonic acid, glucuronic acid, and 4-O-methylglucuronic acid), which form part of polysaccharide or glycosidic structures. The phenolic fraction encompasses flavonoids, tannins, and acetophenone derivatives (2,4-dihydroxy-6-methoxyacetophenone; p-hydroxyacetophenone), contributing to antioxidant capacity. The volatile essential oil fraction is rich in monoterpenes and sesquiterpenes (artemin, artesin, maritimin), imparting the characteristic aroma and pharmacological activity; exact concentrations of individual bioactives in A. afra have not been standardized, though related Artemisia species show artemisinin at 1.9–3.01 mg/g dry weight in leaves. Bioavailability of phenolic compounds is expected to vary with extraction solvent polarity, with hydro-ethanol extracts generally yielding broader phytochemical profiles than aqueous infusions alone.

Preparation & Dosage

- **Traditional Infusion (Tea)**: Dried or fresh leaves steeped in boiling water for 10–15 minutes; consumed as a warm tea for respiratory complaints, fever, and general wellness — no clinically validated dose established for humans.
- **Steam Inhalation**: Fresh leaves placed in boiling water and vapors inhaled directly for bronchitis, congestion, and upper respiratory infections — a widely practiced traditional preparation across Zimbabwe and South Africa.
- **Hydro-ethanol Extract (Research Form)**: Used in preclinical antimalarial studies at IC50 0.46 μg/mL in vitro; animal studies used 200 mg/kg body weight for in vivo efficacy — these doses are research reference points only, not human supplement doses.
- **DCM (Dichloromethane) Leaf Extract**: Used in laboratory settings to achieve 94.28% parasitemia inhibition at 200 mg/kg in murine models; not a commercially available form.
- **Dried Leaf Powder**: Traditionally prepared by drying aerial parts and grinding; used topically or taken orally — no standardized commercial supplement dose has been validated in clinical trials.
- **Standardization**: No commercial standardization percentages for specific bioactives (e.g., artemin, total flavonoids) have been established for A. afra; preparation potency varies with growing region, harvest time, and extraction solvent.

Synergy & Pairings

Artemisia afra is traditionally combined with other African medicinal plants such as Zingiber officinale (ginger) in steam inhalation preparations for respiratory infections, with ginger's gingerols providing complementary anti-inflammatory and mucolytic activity that may enhance the bronchodilatory effects of A. afra's essential oil terpenoids. In the context of antimalarial use, pairing with flavonoid-rich herbs such as Moringa oleifera is hypothesized to amplify antioxidant and immunomodulatory effects by increasing total phenolic load, supporting host defense mechanisms alongside direct parasitostatic activity. Honey is a traditional co-ingredient in A. afra infusions in Zimbabwean folk medicine, likely improving palatability while contributing additional antimicrobial (hydrogen peroxide-mediated) and prebiotic properties that may complement the plant's gastrointestinal applications.

Safety & Interactions

Toxicological studies reviewed in available literature report low adverse effects at traditional doses of A. afra, with no specific toxic side effects identified at customary tea or infusion preparations used in folk medicine across Zimbabwe and southern Africa. No specific drug interaction data for A. afra have been published; however, given the presence of terpenoids and polyphenols with potential CYP450 enzyme modulating activity (a class effect observed in related Artemisia species and flavonoid-rich herbs), caution is warranted when combining with hepatically metabolized drugs including anticoagulants, antimalarials, and antiretrovirals. No formal contraindications have been established in peer-reviewed literature, but the presence of bioactive sesquiterpene lactones and volatile compounds with possible uterotonic effects in related wormwood species warrants avoidance during pregnancy and lactation until human safety data are available. Maximum safe doses for human supplementation have not been established in clinical studies, and individuals with known hypersensitivity to Asteraceae/Compositae family plants (e.g., ragweed, chrysanthemum) should exercise caution due to potential cross-reactivity.